Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 3, 2012
Boston Scientific will participate in the healthcare conference on January 11, 2012. Learn how to watch the webcast or replay.
-
Dec 12, 2011
Boston Scientific's third new peripheral balloon catheter introduced in 2011 strengthens Company's position as a global leader in peripheral angioplasty balloons.
-
Dec 8, 2011World's first and only 16-contact percutaneous lead provides innovative, new option for physicians to treat chronic pain
Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval of the Infinion™ 16 Percutaneous...
-
Nov 30, 2011
Extended ICD/CRT-D program offers warranties up to 10 years
-
Nov 30, 2011
New family of cardiac devices offers excellent longevity and industry's longest warranty.
-
Nov 22, 2011
Approval marks transition to internally manufactured everolimus-eluting stent in the U.S.
-
Nov 18, 2011
Boston Scientific will participate in the healthcare conference on November 30, 2011. Learn how to watch the webcast or replay.
-
Nov 16, 2011
Innovative left atrial appendage closure device offers proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke.
-
Nov 15, 2011
Legislation seeks to improve the ability of companies like Boston Scientific to safely, efficiently and predictably bring new technologies to market.
-
Nov 11, 2011
Positive results from COBRA trial presented at TCT
-
Nov 11, 2011
EVOLVE trial evaluates fourth-generation everolimus-eluting coronary stent with ultra-thin abluminal bioabsorbable polymer.
-
Nov 8, 2011
Carotid WALLSTENT shown to be a safe alternative to carotid endarterectomy (CEA) in patients with carotid artery stenosis who are at increased risk for surgery.
-
Nov 8, 2011
PLATINUM Long Lesion clinical results presented at TCT show no cardiac death, heart attack or stent thrombosis at one year.
-
Nov 8, 2011
Long-term results presented from two studies evaluating advanced paclitaxel-eluting stent.
-
Nov 2, 2011
Multi-center study published in Gastrointestinal Endoscopy is largest ever reported on peroral cholangioscopy.
-
Nov 1, 2011
Clinical presentations to include 12-month data on fourth-generation SYNERGY™ Stent.
-
Oct 27, 2011
Video demonstration of CardioTeach™ app by Dr. Kenneth Stein available online
-
Oct 20, 2011
“Boston Scientific’s POWER strategy is the right top priority for the entire leadership team," said CEO Hank Kucheman.
-
Oct 18, 2011
BWallFlex study includes patients with bile duct strictures associated with post liver transplant anastomosis, prior abdominal surgery and chronic pancreatitis.
-
Oct 17, 2011
Company's everolimus-eluting platinum chromium stent now being marketed in world's second-largest DES market.
-
Oct 14, 2011
Legislation is intended to streamline the medical device review and approval process, reduce regulatory delays and help new medical technologies safely and more expeditiously reach patients.
-
Oct 11, 2011
Boston Scientific will webcast its conference call with financial results and business highlights for Q3 2011 on Thursday, October 20. Learn how to tune in.
-
Oct 5, 2011
Third-generation bare-metal stent designed to offer improved acute performance in treating patients with coronary artery disease
-
Sep 29, 2011
Study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients
-
Sep 28, 2011
U.S. Court of Appeals for the Federal Circuit found in favor of the Company in a 1998 patent infringement suit involving Johnson & Johnson